Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Retrospective Assessment of Outcomes Following Superficial Vein Thrombosis in Cancer Patients

Mina Gendy, DO, Marie Anne Christine Buteau, MD, Marc Braunstein, MD PhD

Blood (2019) 134 (Supplement_1): 3655.

https://doi.org/10.1182/blood-2019-131978

Published: 2019

Journal Articles

Nitrous Oxide Gas May be a Promising Therapy for Acute Priapism in Patients with Sickle Cell Disease: A Case Report

Michael H. Greenwald, Claudia R. Morris, MD

Blood (2017) 130 (Supplement 1): 4802.

https://doi.org/10.1182/blood.V130.Suppl_1.4802.4802

Published: 2017

Journal Articles

Secondary Polycythemia and the Risk of Venous Thromboembolism (VTE) Among Hospitalized Patients in the United States

Smith Giri, MBBS, Kathan Dilipbhai Mehta, MBBS, MPH, Vijaya R. Bhatt, MD

Blood (2016) 128 (22): 1427.

https://doi.org/10.1182/blood.V128.22.1427.1427

Published: 2016

Journal Articles

Iron Unloading By Therapeutic Phlebotomy in Previously Transfused Children with Sickle Cell Anemia: The Twitch Experience

Banu Aygun, MD, Nicole Mortier, PA-C, Zora R. Rogers, MD, William Owen, MD, Beng Fuh, MD, Alex George, MD, PhD, Theodosia A. Kalfa, MD PhD, Janet Kwiatkowski, MD, Margaret Lee, MD, Hamayun Imran, MD, Scott T. Miller, MD, John C Wood, MD PhD, Alan R. Cohen, MD, Sara L Pressel, MS, Russell E. Ware, MD PhD

Blood (2016) 128 (22): 1018.

https://doi.org/10.1182/blood.V128.22.1018.1018

Published: 2016

Journal Articles

Pediatric Emergency Department Use of Intranasal Fentanyl to Treat Pain in Children with Sickel Cell Disease and Its Impact on Discharge Rates: A Multicenter Perspective

Blood (2016) 128 (22): 1306.

https://doi.org/10.1182/blood.V128.22.1306.1306

Published: 2016

Journal Articles

Hospital Associated Venous Thromboembolism in Oklahoma County

Natalie Feland, RN, Aaron Mark Wendelboe, PhD MS, Micah Denay McCumber, BS, MS, Kai Ding, PhD, Dale Bratzler, DO, Nimia Reyes, MD, MPH, Michele Beckman, MPH, Gary E Raskob, PhD

Blood (2016) 128 (22): 416.

https://doi.org/10.1182/blood.V128.22.416.416

Published: 2016

Journal Articles

Management Experience of Peripherally Inserted Central Catheters in Pediatric Oncology Patients: A 15 Year Population-Based Study from Maritimes, Canada

Lisa Borretta, Tamara MacDonald, PharmD, Victoria E. Price, MBChB, MD, Conrad Fernandez, MD, Mark Bernstein, MD, Ketan Kulkarni, MD

Blood (2015) 126 (23): 2074.

https://doi.org/10.1182/blood.V126.23.2074.2074

Published: 2015

Journal Articles

Impact of Erythrocytapheresis on Endogenous Anticoagulants in Sickle Cell Disease

Ruchika Sharma, MD, Gary Woods, BS, MD, Susan E Creary, MD, Kan Hor, MD, Cody Young, MD, Christina Gallagher, RN, BSN, Emily McLain, RN, BSN, Trevorline Mongol, RN, BSN, Brooke Cohen, RN, BSN, Riten Kumar, MD MSc, Amy L. Dunn, MD

Blood (2015) 126 (23): 4590.

https://doi.org/10.1182/blood.V126.23.4590.4590

Published: 2015

Journal Articles

Implementation of a Community Hospital-Based Fast Track Pathway for the Treatment of Acute Pain Episodes in Adults with Sickle Cell Disease

Richard Lottenberg, MD, Robert Krywicki, MD, Gurinder Doad, MD, Witemba Kabange, MD, Monisola Modupe, MD, Gregory Steele, APRN, Zerettia K McGriff, RN,BS, James A Sirleaf, MD, Abdullah Kutlar, MD, Robert Gibson, PhD, Betsy Clair, Matthew L Lyon, MD

Blood (2014) 124 (21): 4854.

https://doi.org/10.1182/blood.V124.21.4854.4854

Published: 2014

Journal Articles

Subcutaneous (SC) Administration Of Bortezomib: A Pilot Survey Of Oncology Nurses

Jasmine R Martin, DNP, MSN, Nancy L Beegle, BSN, MBA, Yanyan Zhu, Ph.D, MPH, Joan M. Agretelis, Ph.D.

Blood (2013) 122 (21): 5585.

https://doi.org/10.1182/blood.V122.21.5585.5585

Published: 2013

Journal Articles

Pain Medication: Time to First Dose in Sickle Cell Acute Care in Two Settings of a Large Urban Hospital

Bonnye Johnson, MS, RN, Dawn Lei, BS, Nicholas F Furtado, MD, Saman K. Hashmi, MD, Robert Molokie, MD, Joseph DeSimone, PhD, Johara Hassan, MD, Michel Gowhari, DO, Tara Gordon, RN, Darcel Dowell, RN, Glenda Pendarvis, RN, Heather Prendergast, MD, Victor R. Gordeuk, MD, Lewis L. Hsu, MD, PhD

Blood (2012) 120 (21): 4693.

https://doi.org/10.1182/blood.V120.21.4693.4693

Published: 2012

Journal Articles

High Diagnostic Utility of Second-Day Factor VIII Levels to Assess Pediatric Hemophilia A Pharmacokinetics

Jacqueline F. Morrison, Rachael F. Grace, MD, Kapil Saxena, MD, Ellis J. Neufeld, MD, PhD

Blood (2012) 120 (21): 3368.

https://doi.org/10.1182/blood.V120.21.3368.3368

Published: 2012

Journal Articles

Use of Emergency-Release, Uncrossmatched O Negative Red Blood Cells (RBCs) in a Tertiary Care Children’s Hospital

Jennifer C. Andrews, Maurene Viele, Lawrence T Goodnough

Blood (2011) 118 (21): 4341.

https://doi.org/10.1182/blood.V118.21.4341.4341

Published: 2011

Journal Articles

A Two-Stage Phase Ib Study to Investigate the Pharmacokinetics, Safety and Tolerability of Subcutaneous Rituximab In Patients with Follicular Lymphoma as Part of Maintenance Treatment

Antonio Salar, Dr., Reda Bouabdallah, Dr., Christine McIntyre, Dr., Pakeeza Sayyed, Dr., Beate Bittner, Dr.

Blood (2010) 116 (21): 2858.

https://doi.org/10.1182/blood.V116.21.2858.2858

Published: 2010

Journal Articles

A Phase 3 Prospective Randomized International Study (MMY-3021) Comparing Subcutaneous and Intravenous Administration of Bortezomib In Patients with Relapsed Multiple Myeloma

Philippe Moreau, Halyna V Pylypenko, Sebastian Grosicki, Evgeniy E Karamanesht, Xavier Leleu, Maria E Grishunina, Grigoriy B Rekhtman, Zvenyslava Masliak, Tadeusz Robak, Anna V Shubina, Jean-Paul Fermand, Martin Kropff, James Cavet, Sudha Parasuraman, Huaibao Feng, Donna M Skee, Helgi van de Velde, William M Deraedt, Jean-Luc Harousseau

Blood (2010) 116 (21): 312.

https://doi.org/10.1182/blood.V116.21.312.312

Published: 2010

Journal Articles

Repeated Doses of Adriamycin May Be Safely Delivered through the Intraosseous Route In Different Bones In Swine

Rodrigo Lima, MD, MS, Lais Navarro, PhD, Fernando Cesani, MD, Hal K. Hawkins, MD, Frederick Huang, MD, PhD, Daneshvari R. Solanki, MD, Thomas Philbeck, PhD, Larry Miller, MD

Blood (2010) 116 (21): 4344.

https://doi.org/10.1182/blood.V116.21.4344.4344

Published: 2010

Journal Articles

Does Deep Venous Thrombosis as Primary Admitting Diagnosis Represent Different Etiologies and Disease Processes as Compared to DVT as Secondary Diagnoses (SD)?

Prabhu Viswanathan, MD, Tanuja Gandhi, MBBS, Lakshmanan Krishnamurti, MD

Blood (2010) 116 (21): 1540.

https://doi.org/10.1182/blood.V116.21.1540.1540

Published: 2010

Journal Articles

Construction of An Outpatient Erythrocytapheresis Program for Pediatric Patients with Sickle Cell Disease

Paulette Bryant, MD, Richard Parmley, MD, Christine Bolen, MD, Theresa Sunderland, MD, Robert Johnson, MD, Jennifer Weisner, PNP, Karen Nishioka, BSN, Karen Roberts, RN, Richard Towell, RN, Jodi P. Strong, MBA, Evelyn Lockhart, MD, Mark Mogul, MD

Blood (2008) 112 (11): 4067.

https://doi.org/10.1182/blood.V112.11.4067.4067

Published: 2008

Journal Articles

A Novel Intravenous Catheter with Self-Operating Pretransfusion Blood Sampling for Enhanced Transfusion Safety: Retrospective Risk Analysis and Prospective Phase II Trial in Emergency Care

Michael Notter, MD, Ariane Storch, Ellen Richter-Loeseke, BSc, Hans-Richard Arntz, MD, Johannes Fakler, MD, Eckhard Thiel, MD, PhD, Ephrath Lahmer-Naim, PhD, Adolf Pfaff, Jan Breckwoldt, MD

Blood (2008) 112 (11): 3046.

https://doi.org/10.1182/blood.V112.11.3046.3046

Published: 2008

Journal Articles

Phase II Study To Determine If Danazol Is an Anti-D Sparing Agent When Used in Combination with Anti-D for the Treatment of Immune Thrombocytopenic Purpura.

Ibrahim N. Nakhoul, MD, Ilan Shapira, MD, May Abdo-Matkiwsky, MD, Peter Kozuch, MD, Etta Frankel, MD, Sree Bhavani Chalasani, MD, Takhir Mirzoyev, Margaret Dietrich, Peter Homel, PhD, Michael L. Grossbard, MD, Mala Varma, MD

Blood (2006) 108 (11): 3983.

https://doi.org/10.1182/blood.V108.11.3983.3983

Published: 2006

NARROW

Retrospective Assessment of Outcomes Following Superficial Vein Thrombosis in Cancer Patients

Nitrous Oxide Gas May be a Promising Therapy for Acute Priapism in Patients with Sickle Cell Disease: A Case Report

Secondary Polycythemia and the Risk of Venous Thromboembolism (VTE) Among Hospitalized Patients in the United States

Iron Unloading By Therapeutic Phlebotomy in Previously Transfused Children with Sickle Cell Anemia: The Twitch Experience

Pediatric Emergency Department Use of Intranasal Fentanyl to Treat Pain in Children with Sickel Cell Disease and Its Impact on Discharge Rates: A Multicenter Perspective

Hospital Associated Venous Thromboembolism in Oklahoma County

Management Experience of Peripherally Inserted Central Catheters in Pediatric Oncology Patients: A 15 Year Population-Based Study from Maritimes, Canada

Impact of Erythrocytapheresis on Endogenous Anticoagulants in Sickle Cell Disease

Implementation of a Community Hospital-Based Fast Track Pathway for the Treatment of Acute Pain Episodes in Adults with Sickle Cell Disease

Subcutaneous (SC) Administration Of Bortezomib: A Pilot Survey Of Oncology Nurses

Pain Medication: Time to First Dose in Sickle Cell Acute Care in Two Settings of a Large Urban Hospital

High Diagnostic Utility of Second-Day Factor VIII Levels to Assess Pediatric Hemophilia A Pharmacokinetics

Use of Emergency-Release, Uncrossmatched O Negative Red Blood Cells (RBCs) in a Tertiary Care Children’s Hospital

A Two-Stage Phase Ib Study to Investigate the Pharmacokinetics, Safety and Tolerability of Subcutaneous Rituximab In Patients with Follicular Lymphoma as Part of Maintenance Treatment

A Phase 3 Prospective Randomized International Study (MMY-3021) Comparing Subcutaneous and Intravenous Administration of Bortezomib In Patients with Relapsed Multiple Myeloma

Repeated Doses of Adriamycin May Be Safely Delivered through the Intraosseous Route In Different Bones In Swine

Does Deep Venous Thrombosis as Primary Admitting Diagnosis Represent Different Etiologies and Disease Processes as Compared to DVT as Secondary Diagnoses (SD)?

Construction of An Outpatient Erythrocytapheresis Program for Pediatric Patients with Sickle Cell Disease

A Novel Intravenous Catheter with Self-Operating Pretransfusion Blood Sampling for Enhanced Transfusion Safety: Retrospective Risk Analysis and Prospective Phase II Trial in Emergency Care

Phase II Study To Determine If Danazol Is an Anti-D Sparing Agent When Used in Combination with Anti-D for the Treatment of Immune Thrombocytopenic Purpura.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only